Study summary

The study objectives of this study are to evaluate the efficacy of ASP8302 compared with placebo in participants with underactive bladder (UAB), to investigate the safety and tolerability of ASP8302 compared with placebo in participants with UAB, to investigate the pharmacokinetics of ASP8302 in participants with UAB and to support the development of the UAB - Patient Reported Outcome (PRO).

Additional Study Details

Phase
2
Product
  • ASP8302
  • Placebo
  • Type
    Interventional
    Masking
    Double (Participant, Investigator)
    Enrollment number
    135
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study of ASP8302 in participants with Underactive Bladder? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site DE49001
      Duisburg, Germany
      Withdrawn
      Site NL31004
      Zwolle, Netherlands
      Completed
      Site JP81013
      Shizuoka, Shizuoka, Japan
      Completed
      Site DE49002
      Duisburg, Germany
      Completed
      Site JP81015
      Sapporo, Hokkaido, Japan
      Completed
      Site SK42101
      Nitra, Slovakia
      Completed
      Site NL31002
      Maastricht, Netherlands
      Completed
      Site JP81012
      Kurashiki, Okayama, Japan
      Completed
      Site JP81008
      Obu, Aichi, Japan
      Completed
      Site UK44002
      Bristol, United Kingdom
      Completed
      Site JP81001
      Shimotsuga-gun, Tochigi, Japan
      Completed
      Site SK42103
      Kosice, Slovakia
      Completed
      Site JP81010
      Saga, Saga, Japan
      Withdrawn
      Site UK44003
      Cambridge, United Kingdom
      Completed
      Site DE49004
      Gronau, Germany
      Completed
      Site PL48004
      Myslowice, Poland
      Completed
      Site PL48002
      Szczecin, Poland
      Withdrawn
      Site UK44001
      Sheffield, United Kingdom
      Completed
      Site DE49003
      Moenchengladbach, Germany
      Completed
      Site JP81002
      Kobe, Hyogo, Japan
      Completed
      Site JP81006
      Asahikawa, Hokkaido, Japan
      Completed
      Site JP81009
      Nagoya, Aichi, Japan
      Completed
      Site PL48001
      Warsaw, Poland
      Completed
      Site JP81004
      Kumamoto, Kumamoto, Japan
      Completed
      Site PL48003
      Piaseczno, Poland
      Completed
      Site JP81011
      Osakasayama, Osaka, Japan
      Completed
      Site NL31003
      Eindhoven, Netherlands
      Completed
      Site JP81005
      Sapporo, Hokkaido, Japan
      Completed
      Site SK42102
      Trencin, Slovakia
      Completed
      Site JP81003
      Fukuoka, Fukuoka, Japan
      Completed
      Site JP81007
      Yoshida-gun, Fukui, Japan
      Completed
      Site NL31001
      Rotterdam, Netherlands

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?